2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2024
JOURNALEndocrine
PREMIER AUTEURMamulashvili Bessac D
TITREOrgan-specific response to [Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors.
ANNÉE2024
JOURNALAnnals of the rheumatic diseases
PREMIER AUTEURSebbag E
TITRE2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
ANNÉE2024
JOURNALAnnals of the rheumatic diseases
PREMIER AUTEURSebbag E
TITRESystematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
ANNÉE2024
JOURNALCancer chemotherapy and pharmacology
PREMIER AUTEURMatheux A
TITREPlasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration.
ANNÉE2024
JOURNALCancers
PREMIER AUTEURPages PB
TITREEvaluation of the Learning Curve Threshold in Robot-Assisted Lung Cancer Surgery: A Nationwide Population-Based Study.
ANNÉE2024
JOURNALDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
PREMIER AUTEURCotte E
TITRERectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR).
ANNÉE2024
JOURNALJournal of medicinal chemistry
PREMIER AUTEURBoos A
TITREAntibody-Vincristine Conjugates as Potent Anticancer Therapeutic Agents.
ANNÉE2024
JOURNALFrontiers in immunology
PREMIER AUTEURGhammem N
TITRECase report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case study.
ANNÉE2024
JOURNALJournal of neuro-oncology
PREMIER AUTEURObara T
TITREHealth-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study.
ANNÉE2024
JOURNALBulletin du cancer
PREMIER AUTEURVignot S
TITRE[A 2024 inventory in oncology news].

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques